Global Adoptive Cell Transfer Therapy Market Growth (Status and Outlook) 2025-2031

According to this study, the global Adoptive Cell Transfer Therapy market size will reach US$ million by 2031.

United States market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Adoptive Cell Transfer Therapy players cover Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Adoptive Cell Transfer Therapy Industry Forecast” looks at past sales and reviews total world Adoptive Cell Transfer Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Adoptive Cell Transfer Therapy sales for 2025 through 2031. With Adoptive Cell Transfer Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adoptive Cell Transfer Therapy industry.

This Insight Report provides a comprehensive analysis of the global Adoptive Cell Transfer Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Adoptive Cell Transfer Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adoptive Cell Transfer Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adoptive Cell Transfer Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adoptive Cell Transfer Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cell Transfer Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
NK
LAK
DC
CIK
CTL
TIL
TCR-T
CAR-T

Segmentation by Application:
Acute Lymphocytic Leukemia
NHL
Melanoma
Bladder Cancer
Lung Cancer
Head and Neck Cancer
Multiple Myeloma
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Athenex
Xiangxue Pharmaceutical (Xiangxue Precision)
Hengrui Yuanzheng
Eureka Therapeutics
WuXi Juno
Shenzhen Inno Immunity
Shenzhen Binde Bio
Kerui Bio
Adaptimmune
Altor Bioscience Corporation
Cellectis
Takara Bio
Unum Therapeutics

Please note: The report will take approximately 2 business days to prepare and deliver. Show more